General practitioners are expressing concern over restrictions to fluticasone on the pharmaceutical benefits scheme, which may be disruptive. The royal australian college of general practitioners is involved in the issue, and there is a related debate about prescribing authority. There are also reports about asthma care and medication, including alternatives and changes to first aid charts, but it is unclear how these are directly related to the fluticasone restrictions.